Overexpression of vascular endothelial growth factor by MCF-7 breast cancer cells promotes estrogen-independent tumor growth in vivo

被引:0
|
作者
Guo, P
Fang, Q
Tao, HQ
Schafer, CA
Fenton, BM
Ding, I
Hu, B
Cheng, SY
机构
[1] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA
[2] Hillman Canc Ctr, Dept Pathol, Pittsburgh, PA 15213 USA
[3] Univ Rochester, Ctr Canc, Rochester, NY 14642 USA
[4] Univ Rochester, Dept Radiat Oncol, Rochester, NY 14642 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Alteration of the phenotype of breast cancers from estrogen-dependent to estrogen-independent growth often leads to the failure of antiestrogenic tumor therapies. We report that overexpression of vascular endothelial growth factor (VEGF) by estrogen-dependent MCF-7 breast cancer cells could abolish estrogen-dependent tumor growth in ovariectomized mice. In the absence of estrogen, MCF-7 VEGF-expressing tumors with increased vessel density showed growth kinetics similar to, or even greater than, that of parental MCF-7 tumors with estrogen supplementation. Overexpression of VEGF by MCF-7 cells or treatment on parental MCF-7 cells with recombinant VEGF also stimulated cell proliferation in culture. Our data suggest that VEGF stimulation of MCF-7 tumor angiogenesis and growth is mediated by both autocrine and paracrine mechanisms.
引用
收藏
页码:4684 / 4691
页数:8
相关论文
共 50 条
  • [1] MTDH Mediates Estrogen-Independent Growth and Tamoxifen Resistance by Down-Regulating PTEN in MCF-7 Breast Cancer Cells
    Xu, Chunyuan
    Kong, Xiaoli
    Wang, Haiji
    Zhang, Ning
    Kong, Xiangnan
    Ding, Xia
    Li, Xiaoyan
    Yang, Qifeng
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2014, 33 (05) : 1557 - 1567
  • [2] Both autocrine and paracrine effects of transfected acidic fibroblast growth factor are involved in the estrogen-independent and antiestrogen-resistant growth of MCF-7 breast cancer cells
    Zhang, LR
    Kharbanda, S
    Hanfelt, J
    Kern, FG
    CANCER RESEARCH, 1998, 58 (02) : 352 - 361
  • [3] ENHANCEMENT OF TUMOR-GROWTH AND VASCULAR DENSITY BY TRANSFECTION OF VASCULAR ENDOTHELIAL-CELL GROWTH-FACTOR INTO MCF-7 HUMAN BREAST-CARCINOMA CELLS
    ZHANG, HT
    CRAFT, P
    SCOTT, PAE
    ZICHE, M
    WEICH, HA
    HARRIS, AL
    BICKNELL, R
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (03) : 213 - 219
  • [4] Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors
    Ram, PT
    Kiefer, T
    Silverman, M
    Song, Y
    Brown, GM
    Hill, SM
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1998, 141 (1-2) : 53 - 64
  • [5] PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide?
    Maioli, E
    Fortino, V
    BRITISH JOURNAL OF CANCER, 2004, 90 (06) : 1293 - 1294
  • [6] PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide?
    E Maioli
    V Fortino
    British Journal of Cancer, 2004, 90 : 1293 - 1294
  • [7] Exposure of Tumor-Associated Macrophages to Apoptotic MCF-7 Cells Promotes Breast Cancer Growth and Metastasis
    Zhou, Na
    Zhang, Yizhuang
    Zhang, Xuehui
    Lei, Zhen
    Hu, Ruobi
    Li, Hui
    Mao, Yiqing
    Wang, Xi
    Irwin, David M.
    Niu, Gang
    Tan, Huanran
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (06) : 11966 - 11982
  • [8] Chronic oxidative stress causes estrogen-independent aggressive phenotype, and epigenetic inactivation of estrogen receptor alpha in MCF-7 breast cancer cells
    Prathap Kumar S. Mahalingaiah
    Logeswari Ponnusamy
    Kamaleshwar P. Singh
    Breast Cancer Research and Treatment, 2015, 153 : 41 - 56
  • [9] Chronic oxidative stress causes estrogen-independent aggressive phenotype, and epigenetic inactivation of estrogen receptor alpha in MCF-7 breast cancer cells
    Mahalingaiah, Prathap Kumar S.
    Ponnusamy, Logeswari
    Singh, Kamaleshwar P.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 153 (01) : 41 - 56
  • [10] Reply: PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide?
    Hoey, RP
    Sanderson, C
    Iddon, J
    Brady, G
    Bundred, NJ
    Anderson, NG
    BRITISH JOURNAL OF CANCER, 2004, 90 (06) : 1295 - 1295